Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Novel Biomarkers to Improve Risk Stratification and Patient Selection in ICD Therapy

NCT01594073 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT01594073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01594073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Novel Biomarkers to Improve Risk Stratification and Patient Selection in ICD Therapy
Lead sponsor
Hannover Medical School
Phase
Observational
Overall status
Completed
Start date
April 30, 2012
Completion date
Not reported
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac death, ventricular arrhythmias